2007
Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions
Forastiere AA, Burtness BA. Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions. Journal Of Clinical Oncology 2007, 25: 2152-2155. PMID: 17538157, DOI: 10.1200/jco.2007.10.9017.Peer-Reviewed Original Research
1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy
Hanania E, Giles R, Kavanagh J, Ellerson D, Zu Z, Wang T, Su Y, Kudelka A, Rahman Z, Holmes F, Hortobagyi G, Claxton D, Bachier C, Thall P, Cheng S, Hester J, Ostrove J, Bird R, Chang A, Korbling M, Seong D, Cote R, Holzmayer T, Mechetner E, Heimfeld S, Berenson R, Burtness B, Edwards C, Bast R, Andreeff M, Champlin R, Deisseroth A. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proceedings Of The National Academy Of Sciences Of The United States Of America 1996, 93: 15346-15351. PMID: 8986814, PMCID: PMC26407, DOI: 10.1073/pnas.93.26.15346.Peer-Reviewed Original ResearchAntineoplastic Combined Chemotherapy ProtocolsATP Binding Cassette Transporter, Subfamily B, Member 1Base SequenceBone MarrowBone Marrow TransplantationBreast NeoplasmsColony-Forming Units AssayCyclophosphamideDNA PrimersEtoposideFemaleGenetic TherapyHematopoietic Stem Cell TransplantationHematopoietic Stem CellsHumansOvarian NeoplasmsPolymerase Chain Reaction